PRCC and pRCC type 1 versus ccRCC displayed a reduced risk of death by 18% and 71%, whereas pRCC type 2 versus 1 revealed a 3.51 times greater risk, though no statistical significance was reached. The gene discussed is PRCC; the disease is nonpapillary renal cell carcinoma.